Praxis Precision Medicines (PRAX) Amortizatization of Intangibles (2021 - 2026)

Praxis Precision Medicines' (PRAX) quarterly Amortizatization of Intangibles came in at $655000.0 in Q1 2026, down 46.7% year-on-year from $1.2 million in Q1 2025, and down 2.38% quarter-over-quarter from $671000.0 in Q4 2025.

Praxis Precision Medicines (PRAX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Praxis Precision Medicines' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $655000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 46.7% year-over-year to $655000.0 in Q1 2026; TTM through Mar 2026 was $3.0 million, a 50.97% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 28.3% from the prior year.
  • Amortizatization of Intangibles fell to $655000.0 in Q1 2026 per PRAX's latest filing, from $671000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.0 million in Q3 2024 and bottomed at -$375000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $655000.0 (2026), against an average of $547133.3.
  • Across the five-year window, Amortizatization of Intangibles soared 76650.0% in 2024 and plunged 64.84% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at -$196000.0 in 2022, then soared by 98.98% to -$2000.0 in 2023, then surged by 69600.0% to $1.4 million in 2024, then plunged by 51.73% to $671000.0 in 2025, then declined by 2.38% to $655000.0 in 2026.
  • Per Business Quant, the three latest PRAX Amortizatization of Intangibles figures stand at $655000.0 (Q1 2026), $671000.0 (Q4 2025), and $705000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Praxis Precision Medicines 9.20 Bn 8.42 Bn - 655,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 655,000.00
Mar 31, 2026 655,000.00
Dec 31, 2025 671,000.00
Dec 31, 2025 671,000.00
Sep 30, 2025 705,000.00
Sep 30, 2025 705,000.00
Jun 30, 2025 987,000.00
Jun 30, 2025 987,000.00
Mar 31, 2025 1.23 Mn
Mar 31, 2025 1.23 Mn
Dec 31, 2024 1.39 Mn
Dec 31, 2024 1.39 Mn
Sep 30, 2024 2.01 Mn
Sep 30, 2024 2.01 Mn
Jun 30, 2024 1.53 Mn
Jun 30, 2024 1.53 Mn
Mar 31, 2024 84,000.00
Mar 31, 2024 84,000.00
Jun 30, 2023 -2,000.00
Jun 30, 2023 -2,000.00